Filing Details
- Accession Number:
- 0001708138-17-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-14 16:36:55
- Reporting Period:
- 2017-06-12
- Filing Date:
- 2017-06-14
- Accepted Time:
- 2017-06-14 16:36:55
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174475 | S Michael Brown | 777 Old Saw Mill River Road Tarrytown NY 10591 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-12 | 2,000 | $177.82 | 2,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-12 | 100 | $472.04 | 1,900 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 100 | $477.05 | 1,800 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 94 | $469.02 | 1,706 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 200 | $473.37 | 1,506 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 900 | $474.37 | 606 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2017-06-12 | 606 | $475.72 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2017-06-12 | 2,000 | $0.00 | 2,000 | $177.82 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,000 | 2023-01-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 17,349 | Indirect | by Trust |
Footnotes
- Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c).
- Represents volume-weighted average price of sales of 94 shares of Company stock on June 12, 2017 at prices ranging from $469.02 to $469.05. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2017 at each separate price.
- Represents volume-weighted average price of sales of 200 shares of Company stock on June 12, 2017 at prices ranging from $473.36 to $473.38. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2017 at each separate price.
- Represents volume-weighted average price of sales of 900 shares of Company stock on June 12, 2017 at prices ranging from $474.01 to $474.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2017 at each separate price.
- Represents volume-weighted average price of sales of 606 shares of Company stock on June 12, 2017 at prices ranging from $475.65 to $475.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on June 12, 2017 at each separate price.
- The stock option becomes exercisable in three equal annual installments, commencing one year after the date of grant.
Billionaire Hedge Funds
